Related Experiment Video
Updated: Mar 6, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Cancer genomics guide clinical practice in personalized medicine
Jacqueline Lehmann-Che1, Brigitte Poirot1, Jean-Christophe Boyer2
1Laboratoire d'oncologie moléculaire, hôpital Saint-Louis, 1, avenue Claude-Vellefaux 75475 Paris cedex 10, France; Unité CNRS UMR7212/U944, équipe de recherche translationnelle en oncologie, bâtiment Jean-Bernard, 75475 Paris, France.
Abstract:
Targeted therapies have revolutionized the treatment of many cancers. Widely developed over the last decade, this new concept of precision medicine relies on the use of genomic technologies to analyze tumor samples in order to identify actionable targets and biomarkers of resistance. The goal is to optimize treatment by identifying which therapeutic approach is best for each patient, i.e. the treatment that is effective, has minimal adverse effects, and avoids unnecessary intervention and cost. The purpose of this review is to highlight, using a few seminal examples of therapeutic targets, the important contribution of appropriate analysis of key oncogenes or driver genes in making clinical decisions. Cancer genomics is now an indispensable part of clinical management. Furthermore, the development of next generation sequencing (NGS) will enable exploration of more and more genes of interest, leading to new treatment options for personalized medicine.
Insights
Precision medicine uses genomic analysis to tailor cancer treatments, identifying optimal therapies for individual patients. This approach enhances effectiveness, minimizes side effects, and reduces costs through targeted gene analysis.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- Targeted therapies represent a significant advancement in cancer treatment.
- Precision medicine leverages genomic technologies to personalize patient care.
- Identifying actionable targets and resistance biomarkers is crucial for optimizing treatment strategies.
Purpose of the Study:
- To review the role of analyzing key oncogenes and driver genes in clinical decision-making.
- To highlight seminal examples of therapeutic targets in cancer treatment.
- To underscore the impact of cancer genomics on personalized medicine.
Main Methods:
- Review of seminal examples of therapeutic targets.
- Analysis of genomic technologies for tumor sample evaluation.
- Discussion of the contribution of oncogene and driver gene analysis.
Main Results:
- Genomic analysis identifies actionable targets and resistance biomarkers.
- Personalized treatment selection optimizes efficacy and minimizes adverse effects.
- Cancer genomics is integral to modern clinical management.
Conclusions:
- Appropriate analysis of key oncogenes and driver genes is vital for clinical decisions.
- Next-generation sequencing (NGS) expands the scope of personalized medicine.
- Genomic-driven approaches are transforming cancer care and leading to new therapeutic options.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...